Oncology
Riotrexate 50
Injection — 50mg
WHO-GMP
Product Overview
Methotrexate is primarily classified as an antimetabolite and an immunosuppressant. It acts as a folic acid antagonist, inhibiting cell division and slowing down the immune system. It is used in treating cancer, severe rheumatoid arthritis (RA), and psoriasis by interfering with DNA synthesis.
Indications
Methotrexate injection is a chemotherapy agent and immune system suppressant used to treat severe cancer types (breast, lung, head/neck, leukemia, lymphoma, osteosarcoma), severe active rheumatoid arthritis, and polyarticular juvenile idiopathic arthritis.
Dosage Forms & Strength
Available Forms
Injection
Strength
50mg
Regulatory Approvals
WHO-GMP